TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent January 27, 2012
TCL Archive Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board June 17, 2011
TCL Archive NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says. November 3, 2000
TCL Archive NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network. July 7, 2006
